CISI FIN (06058) is offering for sale a total of $7 million in notes.

17:25 10/01/2025

Guotai Junan International (06058) issued an announcement. The company's indirectly wholly-owned subsidiary, CISI Investment...

CISI FIN (06058) announced that its indirect wholly-owned subsidiary, CISI Investment, sold notes with a principal amount totaling $7 million (approximately HK$54.95 million) on the open market on January 3, 2025, and January 9, 2025, for a total consideration of approximately $6.9869 million.

CSPC Pharma (01093) signs a strategic cooperation and licensing agreement with AstraZeneca for the development of innovative long-acting peptide drugs.

BLACK SESAME (02533): Liu Weihong has been transferred from an executive director to a non-executive director.

YEEBO (INT'L H)(00259): Suzhou Qingyue is expected to have a shareholder loss of about 74-100 million yuan in 2025.

CSPC Pharma (01093) signs a strategic cooperation and licensing agreement with AstraZeneca for the development of innovative long-acting peptide drugs.

BLACK SESAME (02533): Liu Weihong has been transferred from an executive director to a non-executive director.

YEEBO (INT'L H)(00259): Suzhou Qingyue is expected to have a shareholder loss of about 74-100 million yuan in 2025.